Electrochemotherapy for Desmoid Tumors

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2029

Conditions
Desmoid Fibromatosis
Interventions
PROCEDURE

Electrochemotherapy with bleomycin

Electrochemotherapy (ECT) with bleomycin is a localized treatment approach used for managing desmoid fibromatosis, a benign but locally aggressive tumor. This technique combines electrical pulses with the administration of bleomycin, a chemotherapeutic agent, to enhance drug uptake into tumor cells. The electrical pulses create temporary pores in the cell membranes, allowing bleomycin to enter more effectively, leading to increased cytotoxicity. ECT is typically performed on patients who have not responded to conventional therapies or for whom surgery is not feasible. ECT can lead to significant tumor shrinkage and improvement in symptoms, making it a promising option in the multidisciplinary management of desmoid fibromatosis.

Trial Locations (1)

40136

RECRUITING

IRCCS Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER